Institut Pasteur (IP), Lyon

Tasks in the project:
Hit validation in vitro or in vivo (animal models available of to set up) for compounds with antiviral potential (particularly against BSL4 viruses like arena, bunya, others)

  Human resources

  • Dr Noël Tordo, PhD (M), Head of the UBIVE + Natl/WHO/OIE Ref Centres, expertise in molecular/cellular biology, and antiviral strategies against emerging negative strand RNA viruses
  • Dr Philippe Marianneau, PhD, PI (M), expertise in molecular biology, virology, animal modeldevelopment and experiments (antiviral testing) on BSL4 viruses
  • Dr Sylvain Baize, PhD, PI (M), expertise in immunology, virology of Arenaviruses (Lassa, Mopeia)

Institut Pasteur, Unité de Biologie des Infections Virales Emergentes,
IFR128, 21 av. Tony Garnier,
69365 Lyon cedex 7, France.
Tél: +33 437282440. Mob: +33 683099756. Fax: +33 437282441.

The research leading to these results has received funding from the European Union Seventh Programme (FP7 2007/2013) under grant agreement n°260644-SILVER